SOLV icon

Solventum

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 42.9%
Negative

Neutral
PRNewsWire
2 days ago
Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026
ST. PAUL, Minn., April 14, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2026 financial results on Tuesday, May 5, 2026, after the U.S. financial markets close.
Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026
Negative
Seeking Alpha
2 days ago
1Q26 Earnings: Where Street Estimates Are Too High & Who Should Miss
Solventum (SOLV) is rated Very Unattractive due to negative economic earnings, low ROIC (5%), and an expensive valuation. Street Earnings and significantly overstate SOLV's true profitability; Core Earnings provide a more accurate measure. Solventum's 1Q26 Street EPS estimate is overstated by $0.78/share (58%), with Core EPS at $0.57 versus Street EPS at $1.35.
1Q26 Earnings: Where Street Estimates Are Too High & Who Should Miss
Positive
Zacks Investment Research
3 days ago
SOLV vs. HQY: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical Services sector might want to consider either Solventum (SOLV) or HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
SOLV vs. HQY: Which Stock Should Value Investors Buy Now?
Positive
Zacks Investment Research
7 days ago
Here's Why Solventum (SOLV) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Solventum (SOLV) is a Strong Value Stock
Neutral
Seeking Alpha
8 days ago
Solventum: A Hidden Breakup Story In Healthcare
Solventum has a few good businesses, but the market is treating it as a complicated company. Its main parts are MedSurg, Dental, HIS, and a smaller Water / All Other. The thesis says the stock looks much cheaper than the value of the parts. The business could be worth about $166.6 per share based on SOTP analysis. The main idea is to keep MedSurg as the core business and see more value in the other parts on their own.
Solventum: A Hidden Breakup Story In Healthcare
Positive
Zacks Investment Research
20 days ago
SOLV or HQY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks presents investors with the better value opportunity right now?
SOLV or HQY: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
24 days ago
Why Solventum (SOLV) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Solventum (SOLV) is a Top Value Stock for the Long-Term
Neutral
Zacks Investment Research
28 days ago
Here's Why You Should Hold Solventum Stock in Your Portfolio Now
SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
Here's Why You Should Hold Solventum Stock in Your Portfolio Now
Neutral
Seeking Alpha
29 days ago
Solventum Corporation (SOLV) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
Solventum Corporation (SOLV) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
Solventum Corporation (SOLV) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
Neutral
PRNewsWire
1 month ago
Solventum to Participate in the 2026 KeyBanc Healthcare Forum
ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a virtual fireside chat at the KeyBanc Healthcare Forum on Wednesday, Mar. 18, 2026, beginning at approximately 10:30 a.m.
Solventum to Participate in the 2026 KeyBanc Healthcare Forum